Condition: HIV/AIDS · Sponsor: Guangzhou 8th People's Hospital
To study the safety and effectiveness of CAR-T Cell therapy on HIV patients whose plasma HIV has been successfully suppressed after cART, which is expected to enhance the res-constitution of HIV-specific immune function to assist the eradication of HIV reservoir.
This description comes directly from the study's public registry record.
Li Linghua, Doctor · 020-83710825 · llheliza@126.com
Cai Weiping, Bachelor · 020-83710816 · gz8hcwp@126.com
Always discuss trial participation with your own doctor first.
| Guangzhou 8th People's Hospital | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03240328